
Regenerative technologies are providing an influx of options.
Regenerative technologies are providing an influx of options.
Patient centricity an important driver in topical development.
The various aspects of home monitoring for patients with age-related macular degeneration are discussed in this point/counterpoint by Prof. Rufino Silva, University of Coimbra / Coimbra Hospital and University Centre, Portugal, and Univ.-Prof. Dr. med. Robert P. Finger, PhD, Department of Ophthalmology, University of Bonn, Germany, during the 14th annual Congress on Controversies in Ophthalmology in Lisbon, Portugal.
Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, United States, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
Adequate assessment and estimation of residual visual function are important clinically.
Researchers cite persistent prosopagnosia in the case of a 28-year-old woman.
The findings have potential clinical and public health implications and highlight the greater role of metabolic health status than obesity in IOP elevation, according to the authors.
Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
Session moderators, speakers and audience members all will examine and analyse the most relevant and controversial issues within the field of ophthalmology.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
The procedure can provide prolonged IOP lowering in primary open-angle glaucoma with an excellent safety profile.
Automated AI tool offers offline capability and hope for patients.
EMBL-EBI researchers use UK Biobank data to uncover new information about rare diseases of the eye.
As the company marks its 40-year anniversary, the new rebranding will become official on March 10, 2023, and will be followed by the introduction of new products.
A look at what’s in the therapeutic delivery pipeline for these disorders.
Under the terms of the agreement, Grifols to have worldwide exclusive commercial rights to Selagine’s treatment upon regulatory authorization, expected in early 2029.
The child's changes in vision began at school and worsened over the next day to the point where he could see only outlines and shapes of objects.
Examining the anatomy and physiology may prevent ineffective stent implantation.
Stromal regeneration seems possible in patients with keratoconus.
The technology will be available soon for ophthalmologists in select countries across Asia Pacific and Europe.
The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.
Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
In a presentation at the Asia-Pacific Academy of Ophthalmology Congress in Kuala Lumpur, Malaysia, Kyoko Ohno-Matsui, MD, PhD, noted that changes of scleral curvature and staphyloma edge development may occur in synchronicity.
This marks the first, in-person APAO congress since the COVID-19 pandemic